Rankings
▼
Calendar
ONC Q1 2024 Earnings — BeOne Medicines Ltd. Revenue & Financial Results | Market Cap Arena
ONC
BeOne Medicines Ltd.
$33B
Q1 2024 Earnings
Healthcare
Medical - Pharmaceuticals
Income Statement
Revenue
$752M
+67.9% YoY
Gross Profit
$627M
83.4% margin
Operating Income
-$261M
-34.8% margin
Net Income
-$251M
-33.4% margin
EPS (Diluted)
$-2.47
QoQ Revenue Growth
+18.5%
Cash Flow
Operating Cash Flow
-$309M
Free Cash Flow
-$502M
Stock-Based Comp.
$89M
Balance Sheet
Total Assets
$5.7B
Total Liabilities
$2.3B
Stockholders' Equity
$3.4B
Cash & Equivalents
$2.8B
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$752M
$448M
+67.9%
Gross Profit
$627M
$366M
+71.2%
Operating Income
-$261M
-$371M
+29.6%
Net Income
-$251M
-$348M
+27.9%
← FY 2024
All Quarters
Q2 2024 →